Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01695525 · ClinicalTrials.gov registry record · Early Phase 1
Influence of Yoga in Patients With Neurocardiogenic Syncope
A Early Phase 1 study, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT01695525: Completed Early Phase 1 study, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
NCT01695525 is a Early Phase 1 study that has completed, run by Dhanunjaya Lakkireddy, MD, FACC. The registered enrollment target is 8 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01695525, a Early Phase 1 study, has completed, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
Syncope is a common problem that many clinicians may encounter in various outpatient settings. Neurocardiogenic syncope (NCS) is a benign condition characterized by a self limited episode of systemic hypotension. Patients are usually managed with education on syncope, anxiety management, and coping skills. It has been established that practice of Yoga could relieve stress and anxiety. In a different study, they also found that Yoga positively influences cardiovascular function by decreasing the heart rate and blood pressure. The main objective of Yoga is to achieve control over the autonomic nervous system and able to control functions like heart rate, blood pressure and respiratory rate. Based on the findings that Yoga relieves stress and reduces heart rate, the investigators propose to study if Yoga can decrease the frequency of NCS and also reduce the symptoms associated with these episodes.
Primary Outcome
Differences in the incidence of syncopal spells pre and post Yoga.
Interventions
- OTHER Yoga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-03 |
| Phase | Early Phase 1 |
What the finished NCT01695525 record still lists
NCT01695525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Yoga is the first listed.
NCT01695525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01695525 about?
NCT01695525 is a clinical study titled "Influence of Yoga in Patients With Neurocardiogenic Syncope". Syncope is a common problem that many clinicians may encounter in various outpatient settings. Neurocardiogenic syncope (NCS) is a benign condition characterized by a self limited episode of systemic hypotension. Patients are usually managed with education on syncope, anxiety management, and coping ...
What is the current status of trial NCT01695525?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2012-06. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01695525?
The interventions under investigation include: Yoga (OTHER).
Who is sponsoring clinical trial NCT01695525?
This trial is sponsored by Dhanunjaya Lakkireddy, MD, FACC, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01695525's enrollment target sits among peer trials
8 1783rd of 2000 higher than 176 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia